Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
Ajouter des filtres








Gamme d'année
1.
The Korean Journal of Laboratory Medicine ; : 197-200, 2011.
Article Dans Anglais | WPRIM | ID: wpr-193617

Résumé

Bacillus Calmette-Guerin (BCG) has been traditionally used as a vaccine against tuberculosis. Further, intravesical administration of BCG has been shown to be effective in treating bladder cancer. Although BCG contains a live attenuated strain of Mycobacterium bovis, complications such as M. bovis BCG infection caused by BCG administration are extremely rare. Here, we report a case of BCG infection occurring after intravesical BCG therapy. A 67-yr-old man presented with azotemia and weight loss. He had been diagnosed with bladder cancer 4 yr back, and had undergone transurethral resection of the bladder tumor and intravesical BCG (Tice strain) therapy at that time. An acid-fast bacterial strain was isolated from his urine sample. We did not detect Mycobacterium tuberculosis protein 64 (MPT-64) antigen in the isolates obtained from his sample, and multiplex PCR and PCR-reverse blot hybridization assay indicated that the isolate was a member of the M. tuberculosis complex, but was not M. tuberculosis. Finally, sequence analysis of 16S ribosomal RNA and DNA gyrase, subunit B (gyrB) suggested that the organism was M. bovis or M. bovis BCG. Although we could not confirm that M. bovis BCG was the causative agent, the results of the 3 molecular methods and the MPT-64 antigen assay suggest this finding. This is an important finding, especially because M. bovis BCG cannot be identified using common commercial molecular genetics tools.


Sujets)
Sujet âgé , Humains , Mâle , Administration par voie vésicale , Vaccin BCG/administration et posologie , DNA gyrase/génétique , Infections à Mycobacterium/diagnostic , Mycobacterium bovis/génétique , Réaction de polymérisation en chaîne , ARN ribosomique 16S/génétique , Tumeurs de la vessie urinaire/thérapie
2.
The Korean Journal of Laboratory Medicine ; : 205-211, 2011.
Article Dans Anglais | WPRIM | ID: wpr-193615

Résumé

Streptococcus suis infection is an emerging zoonosis in Asia. The most common disease manifestation is meningitis, which is often associated with hearing loss and cochleovestibular signs. S. suis infection in humans mainly occurs among risk groups that have frequent exposure to pigs or raw pork. Here, we report a case of S. suis meningitis in a 67-yr-old pig carcass handler, who presented with dizziness and sensorineural hearing loss followed by headaches. Gram-positive diplococci were isolated from cerebrospinal fluid (CSF) and blood cultures and showed gray-white colonies with alpha-hemolysis. S. suis was identified from CSF and blood cultures by using a Vitek 2 system (bioMerieux, France), API 20 STREP (bioMerieux), and performing 16S rRNA and tuf gene sequencing. Even after receiving antibiotic treatment, patients with S. suis infection frequently show complications such as hearing impairment and vestibular dysfunction. To the best of our knowledge, this is the first case of S. suis meningitis in Korea. Prevention through public health surveillance is recommended, especially for individuals who have occupational exposures to swine and raw pork.


Sujets)
Sujet âgé , Animaux , Humains , Mâle , Protéines bactériennes/génétique , Sang/microbiologie , Liquide cérébrospinal/microbiologie , Surdité bilatérale partielle/complications , Méningite bactérienne/complications , Phylogenèse , ARN ribosomique 16S/génétique , Analyse de séquence d'ADN , Streptococcus suis/classification , Suidae , Tomodensitométrie
SÉLECTION CITATIONS
Détails de la recherche